ExAblate O.R. The Operation Room of the Future

ExAblate® O.R.  is a new treatment modality that combines the non-invasive capabilities of Focused Ultrasound with the precision of Magnetic Resonance Imaging .  ExAblate's  MRgFUS technology enables precision ablatement of target tissue without surgical intervention.  

ExAblate O.R. is the first and only commercially approved MR guided Focused Ultrasound treatment for Uterine Fibroids and for Adenomyosis. 

ExAblate O.R. now offers a non-ionizing radiation treatment alternative for Pain Palliation of Bone Metastases   or benign tumors such as Osteoid Osteoma

ExAblate's  innovative, industry-transforming technology has earned numerous awards and honors. 

ExAblate O.R -  offering patients the latest in non-invasive treatment options, and physicians the state-of-the-art advantage for their practices,

ExAblate O.R. Benefits

• Safe, non-invasive therapies
• State-of-the-art technology that patients demand
• Clinically proven in thousands of patients and hundreds of peer-reviewed papers
• Consistent, predictable and immediate results
• Few to no side effects
• Quick recovery time
• No incisions or general anesthesia
• No hospital stay – fast return to normal life
• Fertility preserving

"…providing a noninvasive focused treatment requiring minimal hospitalization, preparation and after-care, (MRgFUS) satisfies health economists and patients."

  EA Dick and WMW Gedroyc.  Expert Rev. Med. Devices 7(5), 2010.

* Not all applications are approved in all regions. Please consult your local representatives and read the product labeling specific for your region to determine approved indications for use.

For more information please contact us